BioCentury

12:29 AM GMT, Oct 25, 2012
This article and the information contained in BioCentury's publications and services are solely for your own personal, non-transferable licensed use and cannot be shared with any other individuals. For information about adding subscribers to your account or obtaining article reprints, please contact support@biocentury.com.
Financial News

Regeneron gains on 3Q12 results, Eylea guidance

Regeneron Pharmaceuticals Inc. (NASDAQ:REGN) gained $9.70 to $162.69 on Wednesday after reporting the third full quarter

Read the full 162 word article

This article and the information contained in BioCentury's publications and services are solely for your own personal, non-transferable licensed use and cannot be shared with any other individuals. For information about adding subscribers to your account or obtaining article reprints, please contact support@biocentury.com.